Identification of Flightless-I as a Substrate of the Cytokine-independent Survival Kinase CISK*
- Jun Xu‡,
- Lan Liao§,
- Jun Qin‡§,
- Jianming Xu§,
- Dan Liu‡ and
- Zhou Songyang, Leukemia and Lymphoma Society Scholar‡1
- ‡Verna and Marrs McLean Department of Biochemistry and Molecular Biology and the §Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030
- 1 To whom correspondence should be addressed. Tel.: 713-798-5220; Fax: 713-796-9438; E-mail: songyang{at}bcm.tmc.edu.
Abstract
Phosphatidylinositol (PI) 3-kinase mediates multiple pathways that regulate many aspects of the cell including metabolism, survival, migration, and proliferation. Both Akt and cytokine-independent survival kinase (CISK)/SGK3 are known AGC family protein kinases that function downstream of PI 3-kinase. Although the Akt signaling pathway has been studied extensively, the specific signaling cascades that are modulated by CISK remain to be elucidated. To understand CISK function, we affinity-purified the CISK protein complex and identified Flightless-I (FLII) as a novel downstream target of CISK. Here we show that FLII is an in vivo substrate of CISK that functions downstream of PI 3-kinase. CISK can associate with FLII and phosphorylate FLII at residues Ser436 and Thr818. FLII has been shown to act as a co-activator for nuclear hormone receptors such as estrogen receptor (ER). We demonstrate here that CISK can enhance ER transcription, which is dependent on its kinase activity, and mutation of CISK phosphorylation sites on FLII attenuates its activity as an ER co-activator. Furthermore, FLII knockdown by RNA interference renders 32D cells more sensitive to interleukin-3 withdrawal-induced apoptosis, suggesting that FLII itself is also a survival factor. These findings support the model that CISK phosphorylates FLII and activates nuclear receptor transcription and suggest a new cell survival signaling pathway mediated by PI 3-kinase and CISK.
Footnotes
-
↵2 The abbreviations used are: PI, phosphatidylinositol; CISK, cytokine-independent survival kinase; SGK, serum and glucocorticoid-regulated kinase; FLII, Flightless-I; ER, estrogen receptor; ERE, estrogen-responsive element; shRNA, small hairpin RNA; RNAi, RNA interference; IL, interleukin; PX, Phox homology; E2, 17β-estradiol; E3, ubiquitin-protein isopeptide ligase; HA, hemagglutinin; siRNA, small interfering RNA.
-
↵* This work was supported, in whole or in part, by National Institutes of Health Grants CA84208 and GM069572 (to Z. S.) and CA119689 (to J. M. X.). This work was also supported by funds from the Welch Foundation (to Z. S.).
-
- Received October 8, 2008.
- Revision received March 13, 2009.
- The American Society for Biochemistry and Molecular Biology, Inc.











